Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202197200 on April 8, 2002

J. Biol. Chem., Vol. 277, Issue 24, 21549-21553, June 14, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/24/21549    most recent
M202197200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinberg, R. B.
Right arrow Articles by Steinmetz, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinberg, R. B.
Right arrow Articles by Steinmetz, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Interfacial Exclusion Pressure Determines the Ability of Apolipoprotein A-IV Truncation Mutants to Activate Cholesterol Ester Transfer Protein*

Richard B. WeinbergDagger §, Rachel A. AndersonDagger , Victoria R. CookDagger , Florence Emmanuel||, Patrice Denèfle**, Alan R. TallDagger Dagger , and Armin Steinmetz§§¶¶

From the Departments of Dagger  Internal Medicine and § Physiology & Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, the || Cardiovascular Department, Gencell Division, ** Functional Genomics Center, Aventis Pharma, 94403 Vitry sur Seine, France, the Dagger Dagger  Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, and the §§ St. Nikolaus Stiftshospital Teaching Hospital, University of Bonn, D-56626 Andernach, Germany

We used a panel of recombinant human apolipoprotein (apo) A-IV truncation mutants, in which pairs of 22-mer alpha -helices were sequentially deleted along the primary sequence, to examine the impact of protein structure and interfacial activity on the ability of apoA-IV to activate cholesterol ester transfer protein. Circular dichroism and fluorescence spectroscopy revealed that the secondary structure, conformation, and molecular stability of recombinant human apoA-IV were identical to the native protein. However, deletion of any of the alpha -helical domains in apoA-IV disrupted its tertiary structure and impaired its molecular stability. Surprisingly, determination of the water/phospholipid interfacial exclusion pressure of the apoA-IV truncation mutants revealed that, for most, deletion of amphipathic alpha -helical domains increased their affinity for phospholipid monolayers. All of the truncation mutants activated the transfer of fluorescent-labeled cholesterol esters between high and low density lipoproteins at a rate higher than native apoA-IV. There was a strong positive correlation (r = 0.790, p = 0.002) between the rate constant for cholesterol ester transfer and interfacial exclusion pressure. We conclude that molecular interfacial exclusion pressure, rather than specific helical domains, determines the degree to which apoA-IV, and likely other apolipoproteins, facilitate cholesterol ester transfer protein-mediated lipid exchange.


* This work was supported in part by NHLBI National Institutes of Health Grant HL30897 and American Heart Association Grant-in-Aid 93-013660.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157. Tel.: 336-716-4638; Fax: 336-716-6376; E-mail: weinberg@wfubmc.edu.

¶¶ Recipient of a Heisenberg-Stipendium from the Deutsche Forschungsgemeinschaft.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
A. S. Ledford, V. A. Cook, G. S. Shelness, and R. B. Weinberg
Structural and dynamic interfacial properties of the lipoprotein initiating domain of apolipoprotein B
J. Lipid Res., January 1, 2009; 50(1): 108 - 115.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Lu, Y. Yao, X. Cheng, S. Mitchell, S. Leng, S. Meng, J. W. Gallagher, G. S. Shelness, G. S. Morris, J. Mahan, et al.
Overexpression of Apolipoprotein A-IV Enhances Lipid Secretion in IPEC-1 Cells by Increasing Chylomicron Size
J. Biol. Chem., February 10, 2006; 281(6): 3473 - 3483.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. B. Weinberg, V. R. Cook, J. A. Beckstead, D. D. O. Martin, J. W. Gallagher, G. S. Shelness, and R. O. Ryan
Structure and Interfacial Properties of Human Apolipoprotein A-V
J. Biol. Chem., September 5, 2003; 278(36): 34438 - 34444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement